Plain-English translation of NCT06956742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new device called intermittent intrapulmonary deflation, which works during your natural exhale to help clear mucus from your lungs and reduce the feeling of breathlessness. The device applies gentle negative pressure (like a soft suction) while you breathe out, which may help your lungs empty better and make it easier to exercise. Researchers believe this treatment could help people with COPD feel less short of breath and do more physical activity.
People with COPD often struggle with shortness of breath during and after exercise because their lungs trap too much air and mucus builds up inside them. This treatment represents a new approach to clearing that mucus and improving breathing, addressing a need that current treatments don't fully solve.
You likely qualify if…
You likely don't qualify if…
You would use either the active breathing device or a placebo device (you won't know which) for one week at home while continuing your normal routine. During this week, you'll use the device as instructed and then return for testing to see how it affects your breathing during and after exercise. After a break, you'll repeat the process with the other device (active or placebo) so researchers can compare how each one works for you.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France